Advanced Search
ZHOU Lu, ZHAO Qing, WANG Feng. Research progress of statins in the prevention and treatment of contrast-induced nephropathy[J]. Chin J Clin Med, 2022, 29(2): 288-292. DOI: 10.12025/j.issn.1008-6358.2022.20201739
Citation: ZHOU Lu, ZHAO Qing, WANG Feng. Research progress of statins in the prevention and treatment of contrast-induced nephropathy[J]. Chin J Clin Med, 2022, 29(2): 288-292. DOI: 10.12025/j.issn.1008-6358.2022.20201739

Research progress of statins in the prevention and treatment of contrast-induced nephropathy

  • Contrast-induced nephropathy refers to acute kidney injury secondary to exposure to intravascular iodinated contrast agent. In recent years, a lot of evidence has confirmed the effectiveness and safety of statins in the prevention and treatment of contrast-induced nephropathy. This article reviews the latest research progress of statins in the prevention of contrast-induced nephropathy from the aspects of dose, type, duration of medication, impact of individual differences on the efficacy of statins, and the possible mechanism of its kidney protection effects..
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return